patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Pluristem Therapeutics (PSTI) Approved To List on Nasdaq
was correct on the $4.00 and he said  last evening that it would take  two days or so for the paperwork to be compleated
Share
New Message
Please login to post a reply